Advanced MRI to map brain networks in drug-resistant epilepsy
Tests advanced MRI scans to find seizure networks in people with drug-resistant epilepsy.
Plain-language title generated from the registry record
Registry title: Epileptogenic Network Visualisation With Advanced MRI
Key facts
- Where
- Brussels, BelgiumSee the site
Where in Belgium
- Cliniques Universitaires St-LucBrussels, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Trial code
- NCT06059157
- Record updated
- 15 June 2026
- Original description
The goal of this clinical trial is to improve non-invasive identification of epileptogenic networks in drug-resistant epileptic patient.Read full original descriptionShow less
Epileptogenic Network Visualisation With Advanced MRI
The goal of this clinical trial is to improve non-invasive identification of epileptogenic networks in drug-resistant epileptic patient.
The investigators aim to compare epileptogenic network identification with stereo-EEG (used as glod standard) with the identification of the same network using advanced MRI (rs-fMRI, microstructural analysis of white matter, ...). The main goals are to:
1. Compare the accuracy of network identification. 2. Analyse the effect of the MRI sequences on candidates selection and target identification.
Participants will already have been selected for stereoEEG and will undergo a supplementary MRI (about 1h) with the additional MRI sequences. Follow-up MRI are scheduled for patient undergoing a second, therapeutic epileptic surgery.
Inclusion: Patient suffering from drug-resistant epilepsy; Patient already selected for SEEG implantation as part of their epileptic networks.
Exclusion: Patient excluded from SEEG (pregnant women, children too young for the procedure, patient unable to undergo the procedure); Contra-indication for MRI.